As a consequence of exercise of 247,500 warrants in Vaccibody AS as announced on December 8, 2020, the share capital of Vaccibody AS has been increased by NOK 2,475.00 from NOK 2,845,376.80 to NOK 2,847,851.80. The number of outstanding shares in the company is increased by 247,500 from 284,537,680 to 284,785,180, each with a par value of NOK 0.01.
After the exercise of these warrants, the total number of outstanding warrants in the company is 14,381,430.